Amygdala infusions of an NR2B-selective or an NR2A-preferring NMDA receptor antagonist differentially influence fear conditioning and expression in the fear-potentiated startle test
Open accessThe DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Abstract
Within the amygdala, most N-methyl-D-aspartic acid (NMDA) receptors consist of NR1 subunits in combination with either NR2A or NR2B subunits. Because the particular subunit composition greatly influences the receptors’ properties, we investigated the contribution of both subtypes to fear conditioning and expression. To do so, we infused the NR1/NR2B receptor antagonist CP101,606 (0.5, 1.5, or 4.5 μg/amygdala) or the NR1/NR2A-preferring antagonist NVP-AAM077 (0.075, 0.25, 0.75, or 2.5 μg/amygdala) into the amygdala prior to either fear conditioning (i.e., light-shock pairings) or fear-potentiated startle testing. CP101,606 nonmonotonically disrupted fear conditioning but did not disrupt fear expression. NVP-AAM077 dose-dependently disrupted fear conditioning as well as fear expression. The results suggest that amygdala NR1/NR2B receptors play a special role in fear memory formation, whereas NR1/NR2A receptors participate more generally in synaptic transmission.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Monyer, H., Burnashev, N., Laurie, D. J., Sakmann, B., & Seeburg, P. H. (1994) · Neuron · doi:10.1016/0896-6273(94)90210-0 · Cited by 3,535
NMDA receptor subunits: diversity, development and disease
Cull-Candy, S., Brickley, S., & Farrant, M. (2001) · Current Opinion in Neurobiology · doi:10.1016/s0959-4388(00)00215-4 · Cited by 1,694
Activity level controls postsynaptic composition and signaling via the ubiquitin-proteasome system
Ehlers, M. D. (2003) · Nature Neuroscience · doi:10.1038/nn1013 · Cited by 977
Miserendino, M. J. D., Sananes, C. B., Melia, K. R., & Davis, M. (1990) · Nature · doi:10.1038/345716a0 · Cited by 824 · cited 1×
“The N-methyl-D-aspartic acid (NMDA) receptor antagonist AP5 prevents fear conditioning when infused into the amygdala prior to light-shock (Miserendino et al. 1990; Walker and Davis 2000), tone-shock (Campeau et al.”
BackgroundSelf-citationInteraction with the NMDA receptor locks CaMKII in an active conformation
Bayer, K.-U., De Koninck, P., Leonard, A. S., Hell, J. W., & Schulman, H. (2001) · Nature · doi:10.1038/35081080 · Cited by 732 · cited 1×
“Interestingly, binding of the plasticity-associated enzyme calcium/calmodulin-dependent kinase II (CaMKII) to the NR2B subunit renders CaMKII constitutively active (Bayer et al. 2001), and recent results suggest that this interaction is a major determinant of the magnitude of hippocampal long-term potentiation (LTP) (…”
BackgroundNMDA Receptor Subunit Composition Controls Synaptic Plasticity by Regulating Binding to CaMKII
Barria, A., & Malinow, R. (2005) · Neuron · doi:10.1016/j.neuron.2005.08.034 · Cited by 709 · cited 8×
“Amygdala NMDA receptors of indeterminate subtype are located not only postsynaptically but also presynaptically (Farb et al. 1995), where they are required for the induction of certain types of LTP (Humeau et al. 2003; Samson and Pare 2005) and may regulate neurotransmitter release as well.”
BackgroundInfluentialRodrigues, S. M., Schafe, G. E., & LeDoux, J. E. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-17-06889.2001 · Cited by 350 · cited 2×
“The doses were chosen based on estimates of the relative efficacy of CP101,606 versus the NR1/NR2B antagonist ifenprodil for disrupting NR2B-containing receptor-mediated EPSCs in amygdala neurons (Lopez de Armentia and Sah 2003; Sah and Lopez De Armentia 2003) together with previous dose-response analyses of intra-amy…”
MethodResultN-Methyl-D-aspartate Receptors: Subunit Assembly and Trafficking to the Synapse
Prybylowski, K., & Wenthold, R. J. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.r300029200 · Cited by 137
Walker, D., & Davis, M. (2002) · Psychopharmacology · doi:10.1007/s00213-002-1213-0 · Cited by 122
Self-citation
Cited by
Izquierdo, I., Furini, C. R. G., & Myskiw, J. C. (2016) · Physiological Reviews · doi:10.1152/physrev.00018.2015 · Cited by 453
Neural and cellular mechanisms of fear and extinction memory formation
Orsini, C. A., & Maren, S. (2012) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2011.12.014 · Cited by 429
Milton, A. L., Merlo, E., Ratano, P., Gregory, B. L., Dumbreck, J. K., & Everitt, B. J. (2013) · The Journal of Neuroscience · doi:10.1523/jneurosci.3273-12.2013 · Cited by 183
“The GluN2Apreferring (Auberson et al., 2002) NMDAR antagonist NVP-AAM077 (Sigma-Aldrich) was dissolved in PBS at a concentration of 5 g l 1; this dose has been shown to reduce the expression of fear-potentiated startle (Walker and Davis, 2008).”
MethodResultInfluentialDalton, G. L., Wu, D. C., Wang, Y. T., Floresco, S. B., & Phillips, A. G. (2012) · Neuropharmacology · doi:10.1016/j.neuropharm.2011.09.001 · Cited by 144
Zimmerman, J. M., & Maren, S. (2010) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2010.07223.x · Cited by 127
Importance of the GluN2B carboxy-terminal domain for enhancement of social memories
Jacobs, S., Wei, W., Wang, D., & Tsien, J. Z. (2015) · Learning & Memory · doi:10.1101/lm.038521.115 · Cited by 22
Metadata
- Authors
- Walker, D. L., & Davis, M.
- Venue
- Learning & Memory
- Publisher
- Cold Spring Harbor Laboratory
- Published
- 2008-01-28
- Volume
- 15
- Issue
- 2
- Pages
- 67-74
- ISSN
- 1072-0502 (ISSN-L)
- 1549-5485
- OpenAlex
- W2059057631
- Cited by
- 67
- References
- 9
- Type
- posted content
- Language
- en
- Open access
- diamond
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.